| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 667,400 | 645,225 | 640,691 | 622,636 | | Cost of Revenue | 388,700 | 376,167 | 386,655 | 359,898 | | | Gross Profit | 278,700 | 269,058 | 254,036 | 262,738 | | | Operating Expenses | | Research Development | 42,300 | 47,569 | 45,322 | 39,216 | | Selling General and Administrative | 134,600 | 111,231 | 101,269 | 104,295 | | Non Recurring | (1,500) | 8 | 303 |
-
| | Others | 21,800 | 20,121 | 20,200 | 20,190 | | | | Total Operating Expenses | 197,200 | 178,929 | 167,094 |
-
| | | | Operating Income or Loss | 81,500 | 90,129 | 86,942 | 99,037 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,200 | 3,938 | 14,099 | 7,748 | | Earnings Before Interest And Taxes | 84,700 | 94,067 | 101,041 | 102,802 | | Interest Expense | 4,700 | 7,452 | 7,005 | 6,931 | | Income Before Tax | 80,000 | 86,615 | 94,036 | 95,871 | | Income Tax Expense | 30,900 | 30,229 | 22,975 | 35,568 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 49,100 | 56,386 | 71,061 | 60,303 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 49,100 | 56,386 | 71,061 | 60,303 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $49,100 | $56,386 | $71,061 | $60,303 |
|
0.45% Nasdaq 
0.20%
Income Statement
